News

Skin-lightening products may not be safe, FDA warns

Posted on: 03/09/2015 - 17:38

Use of an injectable skin-lightening product poses a potential health risk to consumers, as no such product has been approved, according to a consumer alert from the Food and Drug...

Field of Interest: Dermatology
Type: News Item

ESC: Celecoxib safety study may soothe cardio concerns

Posted on: 02/09/2015 - 19:44

LONDON – Celecoxib was associated with very low cardiovascular event rates, and its use posed no more risk than other painkillers commonly used to treat elderly individuals with arthritic conditions...

Field of Interest: Rheumatology
Type: News Item

CLL patients achieve remission with CAR-modified T-cells

Posted on: 02/09/2015 - 19:00

Treatment with chimeric antigen receptor (CAR)-modified T cells targeting CD19 achieved a response in 8 of 14 patients (57%) with advanced chronic lymphocytic leukemia (CLL), of whom 4 experienced a...

Field of Interest: Oncology
Type: News Item

Celiac disease ‘as common as psoriasis’

Posted on: 02/09/2015 - 14:48

PARK CITY, UTAH – Dr. John J. Zone first began to study gluten sensitivity in 1977, an interest that left some of his clinician colleagues wondering why. “Everybody told me I was crazy – that this...

Field of Interest: Dermatology
Type: News Item

Celiac disease ‘as common as psoriasis’

Posted on: 02/09/2015 - 14:48

PARK CITY, UTAH – Dr. John J. Zone first began to study gluten sensitivity in 1977, an interest that left some of his clinician colleagues wondering why. “Everybody told me I was crazy – that this...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More